SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : INHL - Inhale Therapeutics - Pulmonary Insulin!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (56)12/22/1997 3:36:00 PM
From: Rick Costantino  Read Replies (1) of 225
 
James,

I decided to get back in INHL today. I have several reason for doing so at this time.

(1) (by far the most important reason) I think the technology is very promising, and there are many drugs intrials for which they would get royalties- in particular, phase III for insulin is an impressive milestone.

(2) I am doing some tax loss selling so I have cash

(3) I am thinking there may be a biotech rally, e.g., Jan effect.

(4) INHL has been weak, but seems more stable lately.

(5) Has support at $25, very strong support at $24, so I doubt it will get much lower.

1998 should be an interesting year if any results come out for the insulin trial. I will continue to look to buy on weakness, but I expect soon we could be back over $30.

Rick Costantino
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext